Skip to main content
Springer Nature Link
Log in

Tobacco Use, Use Disorders, and Smoking Cessation Interventions in Persons Living With HIV

  • Behavioral-Bio-Medical Interface (JL Brown and RJ DiClemente, Section Editors)
  • Published:
Current HIV/AIDS Reports Aims and scope Submit manuscript

Abstract

Cigarette smoking remains highly prevalent among persons living with human immunodeficiency virus (HIV), estimated to be 40–75 %, and is significantly higher than what is observed among the general population. Health risks of smoking in this population include cardiovascular disease; bacterial pneumonia, chronic obstructive pulmonary disease, and other respiratory conditions; lung cancer and other malignancies; adverse cognitive and neurological outcomes; low birth weight, preterm birth, and small-for-gestational-age infants; and overall mortality. Smokers with HIV now lose more life years to smoking than they do to the HIV itself. A majority of smokers living with HIV report being interested in cessation, and a significant proportion has made recent quit attempts. There is a general paucity of large, randomized controlled trials of smoking cessation interventions among smokers living with HIV, and among the existing research, cessation rates are suboptimal. Greater resources and effort should be allocated to developing and evaluating cessation treatment modalities for smokers living with HIV. Efforts to individualize and tailor treatments to address specific client needs and comorbidities are warranted. HIV care providers and other health professionals can play a key role in improving health among this population by regularly screening for smoking and promoting cessation.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Subscribe and save

Springer+ Basic
$34.99 /Month
  • Get 10 units per month
  • Download Article/Chapter or eBook
  • 1 Unit = 1 Article or 1 Chapter
  • Cancel anytime
Subscribe now

Buy Now

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

Papers of particular interest, published recently, have been highlighted as: •• Of major importance

  1. Nakagawa F, May M, Phillips A. Life expectancy living with HIV: recent estimates and future implications. Curr Opin Infect Dis. 2013;26(1):17–25.

    Article  PubMed  Google Scholar 

  2. Helleberg M, Afzal S, Kronborg G, Larsen CS, Pedersen G, Pedersen C, et al. Mortality attributable to smoking among HIV-1-infected individuals: a nationwide, population-based cohort study. Clin Infect Dis. 2013;56(5):727–34. Population-based cohort study that found that HIV-infected smokers currently lose more life years to cigarette smoking than they do to HIV itself.

    Article  PubMed  Google Scholar 

  3. Helleberg M, May MT, Ingle SM, Dabis F, Reiss P, Fätkenheuer G, et al. Smoking and life expectancy among HIV-infected individuals on antiretroviral therapy in Europe and North America. AIDS. 2015;29(2):221–9.

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  4. Shirley DK, Kaner RJ, Glesby MJ. Effects of smoking on non-AIDS-related morbidity in HIV-infected patients. HIV/AIDS. 2013;57:275–82.

    Google Scholar 

  5. Centers for Disease Control and Prevention. Trends in current cigarette smoking among high school students and adults, 1965-2011. 2013. http://www.cdc.gov/tobacco/data_statistics/tables/trends/cig_smoking/. Accessed 13 June 2015.

  6. Centers for Disease Control and Prevention. Current cigarette smoking among adults in the United States. 2015. http://www.cdc.gov/tobacco/data_statistics/fact_sheets/adult_data/cig_smoking/. Accessed 13 June 2015.

  7. Mdodo R, Frazier EL, Dube SR, Mattson CL, Sutton MY, Brooks JT, et al. Cigarette smoking prevalence among adults with HIV compared with the general adult population United States. Ann Intern Med. 2015;162:335–44.

    Article  PubMed  Google Scholar 

  8. Helleberg M, Gerstoft J, Afzal S, Kronborg G, Larsen CS, Pedersen C, et al. Risk of cancer among HIV-infected individuals compared to the background population: impact of smoking and HIV. AIDS. 2014;28:1499–508.

    Article  PubMed  Google Scholar 

  9. Pacek LR, Harrell PT, Martins SS. Cigarette smoking and drug use among a nationally representative sample of HIV-positive individuals. Am J Addict. 2014;23:582–90.

    Article  PubMed  Google Scholar 

  10. Pacek LR, Latkin C, Crum RM, Stuart EA, Knowlton AR. Current cigarette smoking among HIV-positive current and former drug users: associations with individual and social characteristics. AIDS Behav. 2014;18:1368–77.

    Article  PubMed Central  PubMed  Google Scholar 

  11. Pines H, Koutsky L, Buskin S. Cigarette smoking and mortality among HIV-infected individuals in Seattle, Washington (1996-2008). AIDS Behav. 2011;15:243–51.

    Article  PubMed  Google Scholar 

  12. Lifson AR, Neuhaus J, Arribas JR, van den Berg-Wolf M, Labriola AM, Read TRH, et al. Smoking-related health risks among persons with HIV in the Strategies for Management of Antiretroviral Therapy Clinical Trial. Am J Public Health. 2010;100(10):1896–903.

    Article  PubMed Central  PubMed  Google Scholar 

  13. Tesoriero JM, Gieryic SM, Carrascal A, Lavigne HE. Smoking among HIV positive New Yorkers: prevalence, frequency, and opportunities for cessation. AIDS Behav. 2010;14:824–35.

    Article  PubMed  Google Scholar 

  14. Tamí-Maury I, Vidrine DJ, Fletcher FE, Danysh H, Arduino R, Gritz ER. Poly-tobacco use among HIV-positive smokers: implications for smoking cessation efforts. Nicotine Tob Res. 2013;15(12):2100–6.

    Article  PubMed Central  PubMed  Google Scholar 

  15. McQueen A, Shacham E, Summer W, Overton T. Beliefs, experience, and interest in pharmacotherapy among smokers with HIV. Am J Health Behav. 2014;38(2):284–96.

    Article  PubMed Central  PubMed  Google Scholar 

  16. Heatherton TF, Kozlowski LT, Frecker RC, Fagerstrom K. The Fagerström Test for Nicotine Dependence: a revision of the Fagerström Tolerance Questionnaire. Br J Addict. 1991;86:1119–27.

    Article  CAS  PubMed  Google Scholar 

  17. Heatherton TF, Kozlowski LT, Frecker RC, Rickert W, Robinson J. Measuring the heaviness of smoking: using self-reported time to first cigarette of the day and number of cigarettes smoked per day. Br J Addict. 1989;84:791–800.

    Article  CAS  PubMed  Google Scholar 

  18. Fedele F, Bruno N, Mancone M. Cardiovascular risk factors and HIV disease. AIDS Rev. 2011;13:119–29.

    PubMed  Google Scholar 

  19. Freiberg MS, McGinnis KA, Kraemer K, Samet JH, Conigliaro J, Ellison RC, et al. The association between alcohol consumption and prevalent cardiovascular diseases among HIV-infected and HIV-uninfected men. J Acquir Immune Defic Syndr. 2010;53(2):247–53.

    Article  PubMed Central  PubMed  Google Scholar 

  20. Petoumenos K, Worm S, Reiss P, de Wit S, d’Armino Monforte A, Sabin C, et al. Rates of cardiovascular disease following smoking cessation in patients with HIV infection: results from the D:A:D study. HIV Med. 2011;12:412–21.

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  21. De P, Farley A, Lindson N, Aveyard P. Systematic review and meta-analysis: influence of smoking cessation on incidence of pneumonia in HIV. BMC Med. 2013;11(15):1–12.

    Google Scholar 

  22. Cui Q, Carruthers S, McIvor A, Smaill F, Thabane L, Smieja M. Effect of smoking on lung function, respiratory symptoms, and respiratory diseases amongst HIV-positive subjects: a cross-sectional study. AIDS Res Ther. 2010;7(6):1–10.

    Google Scholar 

  23. Madeddu G, Fois AG, Calia GM, Babudieri S, Soddu V, Becciu F, et al. Chronic obstructive pulmonary disease: an emerging comorbidity in HIV-infected patients in the HAART era? Infection. 2013;41:347–53.

    Article  CAS  PubMed  Google Scholar 

  24. National Cancer Institute. Harms of cigarette smoking and health benefits of quitting. 2014. http://www.cancer.gov/about-cancer/causes-prevention/risk/tobacco/cessation-fact-sheet. Accessed 20 June 2014.

  25. Shiels MS, Pfeiffer RM, Gail MH, Hall HI, Li J, Chaturvedi AK, et al. Cancer burden in the HIV-infected population in the United States. J Natl Cancer Inst. 2011;103:753–62.

    Article  PubMed Central  PubMed  Google Scholar 

  26. Vandenhende MA, Roussillon C, Henard S, Morlat P, Oskenhendler E, Aumaitre H, et al. Cancer-related causes of death among HIV-infected patients in France in 2010: evolution since 2010. PLoS One. 2015;10(6):1–12. Combined data from three national surveys conducted in France that showed that the proportion of deaths attributed to AIDS-defining cancers decreased between 2000 and 2010, while the proportion of deaths attributed to non-AIDS/non-hepatitis-related cancers increased significantly during the same time frame.

    Article  Google Scholar 

  27. Franceschi S, Lise M, Clifford GM, Rickenbach M, Levi F, Maspoli M, et al. Changing patterns of cancer incidence in the early- and late-HAART periods: the Swiss HIV Cohort Study. Br J Cancer. 2010;103:416–22.

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  28. Clifford GM, Lise M, Franceschi S, Egger M, Bouchardy C, Korol D, et al. Lung cancer in the Swiss HIV Cohort Study: role of smoking, immunodeficiency, and pulmonary infection. Br J Cancer. 2012;106:447–52.

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  29. Reekie J, Kosa C, Engsig F, Monforte AD, Wiercinska-Drapalo A, Domingo P, et al. Relationship between current level of immunodeficiency and non-acquired immunodeficiency syndrome-defining malignancies. Cancer. 2010;116:5306–15.

    Article  PubMed  Google Scholar 

  30. Bryant VE, Kahler CW, Devlin KN, Monti PM, Cohen RA. The effects of cigarette smoking on learning and memory performance among people living with HIV/AIDS. AIDS Care. 2013;25(10):1308–16.

    Article  PubMed Central  PubMed  Google Scholar 

  31. Benedict RHB, Schretlen A, Groninger L, Brandt J. Hopkins verbal learning test revised: normative data and analysis of inter-form and test-retest reliability. Clin Neuropsychol. 1998;12:43–55.

    Article  Google Scholar 

  32. Benedict RHB. Brief visuospatial memory test—revised. Odessa: Psychological Assessment Resources; 1997.

    Google Scholar 

  33. Maria Jose MB, Richardson E, Vargas M, Espinoza L, Lewis JE, Deshratan A, et al. Mentholated cigarettes are related with abnormal brain-derived neurotrophic factor levels among smokers living with HIV. J Alcohol Drug Depend. 2014;2(5):1–6.

    Google Scholar 

  34. Atluri VSR, Pilakka-Kanthikeel S, Samikkannu T, Sagar V, Kurapati KRV, Saxena SK, et al. Vorinostat positively regulates synaptic plasticity genes expression and spine density in HIV infected neurons: role of nicotine in progression of HIV-associated neurocognitive disorder. Mol Brain. 2014;7(37):1–17.

    Google Scholar 

  35. Aliyu MH, Weldeselasse H, August EM, Keith LG, Salihu HM. Cigarette smoking and fetal morbidity outcomes in a large cohort of HIV-infected mothers. Nicotine Tob Res. 2013;15(1):177–84.

    Article  PubMed  Google Scholar 

  36. Shapiro AE, Tshabangu N, Golub JE, Martinson NA. Intention to quit smoking among human immunodeficiency virus infected adults in Johannesburg, South Africa. Int J Tuberc Lung Dis. 2011;15(1):140–2.

    CAS  PubMed  Google Scholar 

  37. Matthews AK, Vargas MC, Kuhns L, Shivappa N, King A. A qualitative examination of barriers and motivators to smoking cessation among HIV positive African American MSM smokers. J Health Dispar Res Pract. 2014;7(2):50–76.

    Google Scholar 

  38. Pacek LR, Latkin C, Crum RM, Stuart EA, Knowlton AR. Interest in quitting and lifetime quit attempts among smokers living with HIV infection. Drug Alcohol Depend. 2014;138:220–4.

    Article  PubMed Central  PubMed  Google Scholar 

  39. Shuter J, Bernstein SL, Moadel AB. Cigarette smoking behaviors and beliefs in persons living with HIV/AIDS. Am J Health Behav. 2012;36(1):75–85.

    Article  PubMed Central  PubMed  Google Scholar 

  40. Vidrine DJ, Marks RM, Arduino RC, Gritz ER. Efficacy of cell phone-delivered smoking cessation counseling for persons living with HIV/AIDS: 3-month outcomes. Nicotine Tob Res. 2012;14(1):106–10.

    Article  PubMed Central  PubMed  Google Scholar 

  41. Shuter J, Morales DA, Considine-Dunn SE, An LC, Stanton CA. Feasibility and preliminary efficacy of a web-based smoking cessation intervention for HIV-infected smokers: a randomized controlled trial. J Acquir Immune Defic Syndr. 2014;67(1):59–66.

    Article  PubMed Central  PubMed  Google Scholar 

  42. Moadel AB, Bernstein SL, Mermelstein RJ, Arnsten JH, Dolce EH, Shuter J. A randomized controlled trial of a tailored group smoking cessation intervention for HIV-infected smokers. J Acquir Immune Defic Syndr. 2012;61:208–15.

    Article  PubMed Central  PubMed  Google Scholar 

  43. Manuel JK, Lum PJ, Hengl NS, Sorensen JL. Smoking cessation interventions with female smokers living with HIV/AIDS: a randomized pilot study of motivational interviewing. AIDS Care. 2013;25(7):820–7.

    Article  PubMed Central  PubMed  Google Scholar 

  44. Humfleet GL, Hall SM, Kelucchi KL, Dilley JW. A randomized clinical trial of smoking cessation treatments provided in HIV clinical care settings. Nicotine Tob Res. 2013;15(8):1436–45.

    Article  PubMed Central  PubMed  Google Scholar 

  45. Matthews AK, Conrad M, Kuhns L, Vargas M, King AC. Project Exhale: preliminary evaluation of a tailored smoking cessation treatment for HIV-positive African American smokers. AIDS Patient Care STDS. 2013;27(1):22–32.

    Article  PubMed  Google Scholar 

  46. Cui Q, Robinson L, Elston D, Smaill F, Cohen J, Quan C, et al. Safety and tolerability of varenicline tartrate (Champix(®)/Chantix(®)) for smoking cessation in HIV-infected subjects: a pilot open-label study. AIDS Patient Care STDS. 2011;26(1):12–9.

    Article  CAS  PubMed  Google Scholar 

  47. Ferketich AK, Diaz P, Browning KK, Lu B, Koletar SL, Reynolds NR, et al. Safety of varenicline among smokers enrolled in the lung HIV study. Nicotine Tob Res. 2013;15(1):247–54.

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  48. Cropsey KL, Hendricks PS, Jardin B, Clark CB, Katiyar N, Willig J, et al. A pilot study of Screening, Brief Intervention, and Referral for Treatment (SBIRT) in non-treatment seeking smokers with HIV. Addict Behav. 2013;38:2541–6.

    Article  PubMed Central  PubMed  Google Scholar 

  49. Cropsey KL, Jardin B, Burkholder G, Clark CB, Raper JL, Saag M. An algorithm approach to determining smoking cessation treatment for persons living with HIV/AIDS: results of a pilot trial. J Acquir Immune Defic Syndr. 2015;69(3):291–8.

    Article  CAS  PubMed  Google Scholar 

  50. Tidey JW, Rohsenow DJ, Kaplan GB, Swift RM, Reid N. Effects of contingency management and bupropion on cigarette smoking in smokers with schizophrenia. Psychopharmacology. 2011;217:279–87.

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  51. Dunn KE, Sigmon SC, Reimann EF, Badger GJ, Heil SH, Higgins ST. A contingency-management intervention to promote initial smoking cessation among opioid-maintained patients. Exp Clin Psychopharmacol. 2010;18(1):37–50.

    Article  PubMed Central  PubMed  Google Scholar 

Download references

Compliance with Ethics Guidelines

Funding Information

This work was supported by grants from the National Institute on Drug Abuse (T32 DA007209) and the National Institute for Nursing Research (K23 NR-114951).

Conflict of Interest

Lauren R. Pacek and Patricia A. Cioe report grants from NIH but have no other conflicts of interest to declare.

Human and Animal Rights and Informed Consent

This article does not contain any studies with human or animal subjects performed by any of the authors.

Author information

Authors and Affiliations

  1. Department of Psychiatry and Behavioral Sciences, Duke University Medical Center, Durham, NC, 27707, USA

    Lauren R. Pacek

  2. Behavioral Pharmacology Research Unit, Department of Psychiatry and Behavioral Sciences, Johns Hopkins University School of Medicine, Baltimore, MD, 21224, USA

    Lauren R. Pacek

  3. Department of Behavioral and Social Sciences, Center for Alcohol and Addiction Studies, Brown University School of Public Health, Providence, RI, 02912, USA

    Patricia A. Cioe

Authors
  1. Lauren R. Pacek
    View author publications

    You can also search for this author inPubMed Google Scholar

  2. Patricia A. Cioe
    View author publications

    You can also search for this author inPubMed Google Scholar

Corresponding author

Correspondence to Lauren R. Pacek.

Additional information

This article is part of the Topical Collection on Behavioral-Bio-Medical Interface

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Pacek, L.R., Cioe, P.A. Tobacco Use, Use Disorders, and Smoking Cessation Interventions in Persons Living With HIV. Curr HIV/AIDS Rep 12, 413–420 (2015). https://doi.org/10.1007/s11904-015-0281-9

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s11904-015-0281-9

Keywords